Ambrosetti D - Search Results

1

RBM10-TFE3 fusions: A FISH-concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel cases.

Di Mauro I, Dadone-Montaudie B, Sibony M, Ambrosetti D, Molinie V, Decaussin-Petrucci M, Bland V, Arbaud C, Cenciu B, Arbib F, Just PA, Derman J, Rioux-Leclercq N, Pedeutour F; CARARE French Network. Di Mauro I, et al. Among authors: ambrosetti d. Genes Chromosomes Cancer. 2021 Nov;60(11):772-784. doi: 10.1002/gcc.22985. Epub 2021 Aug 6. Genes Chromosomes Cancer. 2021. PMID: 34358382

2

Rearrangement of HMGA2 in a case of infantile lipoblastoma without Plag1 alteration.

Pedeutour F, Deville A, Steyaert H, Ranchere-Vince D, Ambrosetti D, Sirvent N. Pedeutour F, et al. Among authors: ambrosetti d. Pediatr Blood Cancer. 2012 May;58(5):798-800. doi: 10.1002/pbc.23335. Epub 2012 Jan 6. Pediatr Blood Cancer. 2012. PMID: 22223189

3

EGFR mutation status in brain metastases of non-small cell lung carcinoma.

Burel-Vandenbos F, Ambrosetti D, Coutts M, Pedeutour F. Burel-Vandenbos F, et al. Among authors: ambrosetti d. J Neurooncol. 2013 Jan;111(1):1-10. doi: 10.1007/s11060-012-0990-5. Epub 2012 Oct 20. J Neurooncol. 2013. PMID: 23086434 Review.

4

Renal cell carcinoma and a constitutional t(11;22)(q23;q11.2): case report and review of the potential link between the constitutional t(11;22) and cancer.

Doyen J, Carpentier X, Haudebourg J, Hoch B, Karmous-Benailly H, Ambrosetti D, Fabas T, Amiel J, Lambert JC, Pedeutour F. Doyen J, et al. Among authors: ambrosetti d. Cancer Genet. 2012 Nov;205(11):603-7. doi: 10.1016/j.cancergen.2012.09.006. Epub 2012 Oct 30. Cancer Genet. 2012. PMID: 23117075

5

Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of β-catenin in this unusual lesion of the jaws.

Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T. Harnet JC, et al. Among authors: ambrosetti d. J Oral Maxillofac Surg. 2013 Apr;71(4):706-13. doi: 10.1016/j.joms.2012.10.006. Epub 2012 Dec 20. J Oral Maxillofac Surg. 2013. PMID: 23265580 Review.

6

A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?

Dadone B, Ambrosetti D, Carpentier X, Duranton-Tanneur V, Burel-Vandenbos F, Amiel J, Pedeutour F. Dadone B, et al. Among authors: ambrosetti d. Cancer Genet. 2013 Sep-Oct;206(9-10):347-52. doi: 10.1016/j.cancergen.2013.09.002. Cancer Genet. 2013. PMID: 24432405

7

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Grépin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F, Pagès G. Grépin R, et al. Among authors: ambrosetti d. PLoS One. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449. eCollection 2014. PLoS One. 2014. PMID: 24676409 Free PMC article.

8

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.

Marsaud A, Dadone B, Ambrosetti D, Baudoin C, Chamorey E, Rouleau E, Lefol C, Roussel JF, Fabas T, Cristofari G, Carpentier X, Michiels JF, Amiel J, Pedeutour F. Marsaud A, et al. Among authors: ambrosetti d. Genes Chromosomes Cancer. 2015 Jun;54(6):369-82. doi: 10.1002/gcc.22248. Epub 2015 Mar 28. Genes Chromosomes Cancer. 2015. PMID: 25820192

9

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Dufies M, Giuliano S, Viotti J, Borchiellini D, Cooley LS, Ambrosetti D, Guyot M, Ndiaye PD, Parola J, Claren A, Schiappa R, Gal J, Frangeul A, Jacquel A, Cassuto O, Grépin R, Auberger P, Bikfalvi A, Milano G, Escudier B, Rioux-Leclercq N, Porta C, Negrier S, Chamorey E, Ferrero JM, Pagès G. Dufies M, et al. Among authors: ambrosetti d. Br J Cancer. 2017 Sep 26;117(7):947-953. doi: 10.1038/bjc.2017.276. Epub 2017 Aug 29. Br J Cancer. 2017. PMID: 28850564 Free PMC article. Clinical Trial.

10

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.

Dadone-Montaudié B, Ambrosetti D, Dufour M, Darcourt J, Almairac F, Coyne J, Virolle T, Humbert O, Burel-Vandenbos F. Dadone-Montaudié B, et al. Among authors: ambrosetti d. PLoS One. 2017 Sep 22;12(9):e0184625. doi: 10.1371/journal.pone.0184625. eCollection 2017. PLoS One. 2017. PMID: 28937983 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page